Seaford Pharmaceuticals

Seaford Pharmaceuticals is a privately held Canadian specialty pharmaceutical company headquartered in Mississauga, Ontario. Founded in 1991, the company specializes in the development and commercialization of niche healthcare products across therapeutic areas such as hematology, gastroenterology, dermatology, and nutrition. Seaford is best known for its FeraMAX line of polydextrose iron complex supplements, which are widely used for the treatment of iron deficiency anemia. The company focuses on providing high-quality, innovative solutions for unmet medical needs within the Canadian healthcare system. By partnering with international manufacturers and leveraging its local expertise, Seaford maintains a robust portfolio of both over-the-counter and prescription products.